Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 1
1(33.3%)
3Total
N/A(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02382497Not ApplicableUnknown

New Treatment Perspectives in Eating Disorders: the Efficacy of Non-invasive Brain-directed Treatment

Role: lead

NCT02960867Completed

European Registry of Dialysis Treatment of Pediatric Acute Kidney Injury (AKI)

Role: lead

NCT02343016Terminated

NIRS as a Continuous Noninvasive Monitoring System of Liver/Kidney Graft Perfusion

Role: lead

NCT01810120Phase 1Completed

Trial to Assess the Efficacy of a TCR Alfa Beta Depleted Graft in Pediatric Affected by ALL or AML and Receiving an HSCT

Role: lead

NCT02965612Not ApplicableUnknown

Specific Immunotherapy for Allergic Child

Role: lead

All 5 trials loaded